101 related articles for article (PubMed ID: 11093725)
1. Increased hepatic iron and cirrhosis: no evidence for an adverse effect on patient outcome following liver transplantation.
Stuart KA; Fletcher LM; Clouston AD; Lynch SV; Purdie DM; Kerlin P; Crawford DH
Hepatology; 2000 Dec; 32(6):1200-7. PubMed ID: 11093725
[TBL] [Abstract][Full Text] [Related]
2. Iron overload in cirrhosis-HFE genotypes and outcome after liver transplantation.
Brandhagen DJ; Alvarez W; Therneau TM; Kruckeberg KE; Thibodeau SN; Ludwig J; Porayko MK
Hepatology; 2000 Feb; 31(2):456-60. PubMed ID: 10655270
[TBL] [Abstract][Full Text] [Related]
3. Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry.
Kowdley KV; Brandhagen DJ; Gish RG; Bass NM; Weinstein J; Schilsky ML; Fontana RJ; McCashland T; Cotler SJ; Bacon BR; Keeffe EB; Gordon F; Polissar N;
Gastroenterology; 2005 Aug; 129(2):494-503. PubMed ID: 16083706
[TBL] [Abstract][Full Text] [Related]
4. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
5. Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.
Nahon P; Sutton A; Rufat P; Ziol M; Thabut G; Schischmanoff PO; Vidaud D; Charnaux N; Couvert P; Ganne-Carrie N; Trinchet JC; Gattegno L; Beaugrand M
Gastroenterology; 2008 Jan; 134(1):102-10. PubMed ID: 18061182
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for hereditary hemochromatosis.
Brandhagen DJ
Liver Transpl; 2001 Aug; 7(8):663-72. PubMed ID: 11510009
[TBL] [Abstract][Full Text] [Related]
7. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
8. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosis.
Nahon P; Ganne-Carrié N; Trinchet JC; Beaugrand M
Gastroenterol Clin Biol; 2010 Jan; 34(1):1-7. PubMed ID: 19762191
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the HFE gene and the risk of hepatocellular carcinoma.
Racchi O; Mangerini R; Rapezzi D; Gaetani GF; Nobile MT; Picciotto A; Ferraris AM
Blood Cells Mol Dis; 1999; 25(5-6):350-3. PubMed ID: 10660482
[TBL] [Abstract][Full Text] [Related]
10. Histological evaluation of iron in liver biopsies: relationship to HFE mutations.
Brunt EM; Olynyk JK; Britton RS; Janney CG; Di Bisceglie AM; Bacon BR
Am J Gastroenterol; 2000 Jul; 95(7):1788-93. PubMed ID: 10925986
[TBL] [Abstract][Full Text] [Related]
11. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
[TBL] [Abstract][Full Text] [Related]
12. The influence of hemochromatosis mutations on iron overload of thalassemia major.
Longo F; Zecchina G; Sbaiz L; Fischer R; Piga A; Camaschella C
Haematologica; 1999 Sep; 84(9):799-803. PubMed ID: 10477452
[TBL] [Abstract][Full Text] [Related]
13. Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosis.
Noor MT; Tiwari M; Kumar R
Indian J Gastroenterol; 2016 Jan; 35(1):33-9. PubMed ID: 26873085
[TBL] [Abstract][Full Text] [Related]
14. [Iron in the era of molecular biology].
Deugnier Y; Moirand R; Brissot P; David V
Pathol Biol (Paris); 1999 Nov; 47(9):938-44. PubMed ID: 10609274
[TBL] [Abstract][Full Text] [Related]
15. Is there a threshold of hepatic iron concentration that leads to cirrhosis in C282Y hemochromatosis?
Adams PC
Am J Gastroenterol; 2001 Feb; 96(2):567-9. PubMed ID: 11232708
[TBL] [Abstract][Full Text] [Related]
16. Pathology of hepatic iron overload.
Deugnier Y; Turlin B
World J Gastroenterol; 2007 Sep; 13(35):4755-60. PubMed ID: 17729397
[TBL] [Abstract][Full Text] [Related]
17. Iron overload secondary to cirrhosis: a mimic of hereditary haemochromatosis?
Abu Rajab M; Guerin L; Lee P; Brown KE
Histopathology; 2014 Oct; 65(4):561-9. PubMed ID: 24635122
[TBL] [Abstract][Full Text] [Related]
18. HFE mutations in insulin resistance-associated hepatic iron overload.
Guillygomarc'h A; Mendler MH; Moirand R; Jouanolle AM; David V; Deugnier Y
J Hepatol; 2000 Sep; 33(3):515-6. PubMed ID: 11020014
[No Abstract] [Full Text] [Related]
19. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
[TBL] [Abstract][Full Text] [Related]
20. Relation between HFE mutations and mild iron-overload expression.
Mura C; Le Gac G; Raguénes O; Mercier AY; Le Guen A; Férec C
Mol Genet Metab; 2000 Apr; 69(4):295-301. PubMed ID: 10870847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
